Prospective Studies Comparing Structured Vs Nonstructured Diagnostic Protocol Evaluations Among Patients With Fever of Unknown Origin: A Systematic Review and Meta-analysis

Overview

Journal JAMA Netw Open

Publisher American Medical Association

Specialty General Medicine

Date 2022 Jun 2

PMID 35653154

Authors

William F Wright

Joshua F Betz

Paul G Auwaerter

Affiliations

Soon will be listed here.

Abstract

Importance: Patients meeting the criteria for fever of unknown origin (FUO) can be evaluated with structured or nonstructured approaches, but the optimal diagnostic method is unresolved.

Objective: To analyze differences in diagnostic outcomes among patients undergoing structured or nonstructured diagnostic methods applied to prospective clinical studies.

Data Sources: PubMed, Embase, Scopus, and Web of Science databases with librarian-generated query strings for FUO, PUO, fever or pyrexia of unknown origin, clinical trial, and prospective studies identified from January 1, 1997, to March 31, 2021.

Study Selection: Prospective studies meeting any adult FUO definition were included. Articles were excluded if patients did not precisely fit any existing adult FUO definition or studies were not classified as prospective.

Data Extraction And Synthesis: Abstracted data included years of publication and study period, country, setting (eg, university vs community hospital), defining criteria and category outcome, structured or nonstructured diagnostic protocol evaluation, sex, temperature threshold and measurement, duration of fever and hospitalization before final diagnoses, and contribution of potential diagnostic clues, biochemical and immunological serologic studies, microbiology cultures, histologic analysis, and imaging studies. Structured protocols compared with nonstructured diagnostic methods were analyzed using regression models.

Main Outcomes And Measures: Overall diagnostic yield was the primary outcome.

Results: Among the 19 prospective trials with 2627 unique patients included in the analysis (range of patient ages, 10-94 years; 21.0%-55.3% female), diagnoses among FUO series varied across and within World Health Organization (WHO) geographic regions. Use of a structured diagnostic protocol was not significantly associated with higher odds of yielding a diagnosis compared with nonstructured protocols in aggregate (odds ratio [OR], 0.98; 95% CI, 0.65-1.49) or between Western Europe (Belgium, France, the Netherlands, and Spain) (OR, 0.95; 95% CI, 0.49-1.86) and Eastern Europe (Turkey and Romania) (OR, 0.83; 95% CI, 0.41-1.69). Despite the limited number of studies in some regions, analyses based on the 6 WHO geographic areas found differences in the diagnostic yield. Western European studies had the lowest percentage of achieving a diagnosis. Southeast Asia led with infections at 49.0%. Noninfectious inflammatory conditions were most prevalent in the Western Pacific region (34.0%), whereas the Eastern Mediterranean region had the highest proportion of oncologic explanations (24.0%).

Conclusions And Relevance: In this systematic review and meta-analysis, diagnostic yield varied among WHO regions. Available evidence from prospective studies did not support that structured diagnostic protocols had a significantly better rate of achieving a diagnosis than nonstructured protocols. Clinicians worldwide should incorporate geographical disease prevalence in their evaluation of patients with FUO.

Citing Articles

Onco-mNGS facilitates rapid and precise identification of the etiology of fever of unknown origin: a single-centre prospective study in North China.

Liu B, Yu T, Ren R, Wu N, Xing N, Wang J BMC Infect Dis. 2024; 24(1):1475.

PMID: 39732661 PMC: 11682622. DOI: 10.1186/s12879-024-10383-3.

Recommendations for Updating Fever and Inflammation of Unknown Origin From a Modified Delphi Consensus Panel.

Wright W, Stelmash L, Betrains A, Mulders-Manders C, Rovers C, Vanderschueren S Open Forum Infect Dis. 2024; 11(7):ofae298.

PMID: 38966848 PMC: 11222709. DOI: 10.1093/ofid/ofae298.

Nuclear Medicine Imaging Tools in Fever of Unknown Origin: Time for a Revisit and Appropriate Use Criteria.

Wright W, Kandiah S, Brady R, Shulkin B, Palestro C, Jain S Clin Infect Dis. 2024; 78(5):1148-1153.

PMID: 38441140 PMC: 11093677. DOI: 10.1093/cid/ciae115.

Development of a Consensus-Based List of Potential Quality Indicators for Fever and Inflammation of Unknown Origin.

Wright W, Betrains A, Stelmash L, Mulders-Manders C, Rovers C, Vanderschueren S Open Forum Infect Dis. 2024; 11(2):ofad671.

PMID: 38333881 PMC: 10853001. DOI: 10.1093/ofid/ofad671.

Microbial and Host Metabolites at the Backstage of Fever: Current Knowledge about the Co-Ordinate Action of Receptors and Molecules Underlying Pathophysiology and Clinical Implications.

Santacroce L, Colella M, Charitos I, Di Domenico M, Palmirotta R, Jirillo E Metabolites. 2023; 13(3).

PMID: 36984901 PMC: 10056708. DOI: 10.3390/metabo13030461.

References

Torne Cachot J, Baucells Azcona J, Blanch Falp J, Camell Ilari H . Classic fever of unknown origin: analysis of a cohort of 87 patients according to the definition with qualitative study criterion. Med Clin (Barc). 2020; 156(5):206-213. DOI: 10.1016/j.medcli.2020.03.014. View

Wu Z, Xing M, Wei S, Zhao M, Wang W, Zhu L . Establishment of a Predictive Model Related to Pathogen Invasion for Infectious Diseases and Its Diagnostic Value in Fever of Unknown Origin. Curr Med Sci. 2018; 38(6):1025-1031. DOI: 10.1007/s11596-018-1979-x. View

Ramoni R, Mulvihill J, Adams D, Allard P, Ashley E, Bernstein J . The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease. Am J Hum Genet. 2017; 100(2):185-192. PMC: 5294757. DOI: 10.1016/j.ajhg.2017.01.006. View

Altiparmak M, Apaydin S, Ataman R, Tabak F, Mert A, Serdengecti K . Fever of unknown origin in uremic patients: a controlled prospective study. Scand J Infect Dis. 2002; 33(11):851-3. DOI: 10.1080/713933774. View

Wright W, Simner P, Carroll K, Auwaerter P . Progress Report: Next-Generation Sequencing, Multiplex Polymerase Chain Reaction, and Broad-Range Molecular Assays as Diagnostic Tools for Fever of Unknown Origin Investigations in Adults. Clin Infect Dis. 2021; 74(5):924-932. DOI: 10.1093/cid/ciab155. View

Naito T, Tanei M, Ikeda N, Ishii T, Suzuki T, Morita H . Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study. BMJ Open. 2019; 9(11):e032059. PMC: 6886908. DOI: 10.1136/bmjopen-2019-032059. View

Hoffmann K, Ristl R, George A, Maier M, Pichlhofer O . The ecology of medical care: access points to the health care system in Austria and other developed countries. Scand J Prim Health Care. 2019; 37(4):409-417. PMC: 6883430. DOI: 10.1080/02813432.2019.1663593. View

Mansueto P, Di Lorenzo G, Rizzo M, Di Rosa S, Vitale G, Rini G . Fever of unknown origin in a Mediterranean survey from a division of internal medicine: report of 91 cases during a 12-year-period (1991-2002). Intern Emerg Med. 2008; 3(3):219-25. DOI: 10.1007/s11739-008-0129-z. View

Vanderschueren S, Knockaert D, Adriaenssens T, Demey W, Durnez A, Blockmans D . From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med. 2003; 163(9):1033-41. DOI: 10.1001/archinte.163.9.1033. View

10.

de Kleijn E, van der Meer J . Inquiry into the diagnostic workup of patients with fever of unknown origin. Neth J Med. 1997; 50(2):69-74. DOI: 10.1016/s0300-2977(96)00086-1. View

11.

Ali-Eldin F, Abdelhakam S, Ali-Eldin Z . Clinical spectrum of fever of unknown origin among adult Egyptian patients admitted to Ain Shams University Hospitals: a hospital based study. J Egypt Soc Parasitol. 2011; 41(2):379-86. View

12.

de Kleijn E, Vandenbroucke J, van der Meer J . Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore). 1997; 76(6):392-400. DOI: 10.1097/00005792-199711000-00002. View

13.

Robine A, Hot A, Maucort-Boulch D, Iwaz J, Broussolle C, Seve P . Fever of unknown origin in the 2000s: evaluation of 103 cases over eleven years. Presse Med. 2014; 43(9):e233-40. DOI: 10.1016/j.lpm.2014.02.026. View

14.

Wright W, Mulders-Manders C, Auwaerter P, Bleeker-Rovers C . Fever of Unknown Origin (FUO) - A Call for New Research Standards and Updated Clinical Management. Am J Med. 2021; 135(2):173-178. DOI: 10.1016/j.amjmed.2021.07.038. View

15.

Petersdorf R, Beeson P . Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961; 40:1-30. DOI: 10.1097/00005792-196102000-00001. View

16.

Ergonul O, Willke A, Azap A, Tekeli E . Revised definition of 'fever of unknown origin': limitations and opportunities. J Infect. 2004; 50(1):1-5. DOI: 10.1016/j.jinf.2004.06.007. View

17.

Kucukardali Y, Oncul O, Cavuslu S, Danaci M, Calangu S, Erdem H . The spectrum of diseases causing fever of unknown origin in Turkey: a multicenter study. Int J Infect Dis. 2007; 12(1):71-9. DOI: 10.1016/j.ijid.2007.04.013. View

18.

Iikuni Y, Okada J, Kondo H, Kashiwazaki S . Current fever of unknown origin 1982-1992. Intern Med. 1994; 33(2):67-73. DOI: 10.2169/internalmedicine.33.67. View

19.

Saltoglu N, Tasova Y, Midikli D, Aksu H, Sanli A, Dundar I . Fever of unknown origin in Turkey: evaluation of 87 cases during a nine-year-period of study. J Infect. 2003; 48(1):81-5. DOI: 10.1016/j.jinf.2003.08.006. View

20.

Baicus C, Bolosiu H, Tanasescu C, Baicus A . Fever of unknown origin-predictors of outcome. A prospective multicenter study on 164 patients. Eur J Intern Med. 2003; 14(4):249-254. DOI: 10.1016/s0953-6205(03)00075-x. View